EP0484442A1 - Oximeters - Google Patents
OximetersInfo
- Publication number
- EP0484442A1 EP0484442A1 EP19900912344 EP90912344A EP0484442A1 EP 0484442 A1 EP0484442 A1 EP 0484442A1 EP 19900912344 EP19900912344 EP 19900912344 EP 90912344 A EP90912344 A EP 90912344A EP 0484442 A1 EP0484442 A1 EP 0484442A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- light
- blood
- wavelength
- oximeter
- oxygen saturation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3
Definitions
- OXIMETERS This invention relates to oximeters, devices to measure the oxygen saturation of blood.
- pulse oximeters use radiation at two or more wavelengths, one in the red region (650 to 750 nanometers) and another in the infra-red region ( above 750 nanometers).
- the measurements of detected transmitted or reflected intensities are compared on the basis of the Lambert-Beers transmittance law to estimate oxygen saturation. Such comparative measurements are prone to error for various reasons:-
- this "colour value” can provide information about the sample by using the ratiometric colour value to derive physical data from a look-up table.
- the colour value of a blood sample can give information about oxygen saturation of blood by being accurately indicative of the transmission wavelength. No specific wavelengths for the photodetectors are given.
- the quotient of the two photodetector outputs is the significant signal from the essentially comparative technique. Comparison of output signals to produce a potentially useful value is the basis of all the above techniques which can suffer from various defects as set out earlier.
- a method of measuring the oxygen saturation of blood of a subject including examining the absorption characteristic of said blood on a nanometric basis over a wavelength range within the range of 350 to 600 nanometers, determining the nanometric specific absorption characteristic and directly from the wavelength shift of said specific absorption characteristic from the known pysyiological endpoints the actual oxygen saturation percentage.
- the method may include directing the light along blood measurement and reference paths, selecting the light from said paths in turn, and applying the selected light to an optical detector.
- the blood may be in the subject or as a sample.
- the method may include varying the wavelengh of the light on a nanometric basis or illuminating the blood with a band of wavelengths of light, dispersing the light from the illuminated blood as a spectrum and examining the spectrum for said wavelength shift of said characteristic.
- an oximeter including means to provide light in a band of wavelengths at least over a range lying within 350 to 600 nanometers, means to apply said light to a blood measurement path, means to disperse light received from said path as a spectrum and means to detect light of said spectrum to determine the specific absorption characteristic of the blood measurement path and means to indicate from the nanometric shift of said characteristic the oxygen saturation of blood in said blood measurement path.
- an oximeter including means to provide light of a wavelength nanometrically controllably variable within a range between 350 to 600 nanometers, means to apply said light of controllably variable wavelength to a blood measurement path, means to detect light received from said path and determine the specific absorption characteristic of the blood measurement path and means to indicate from the nanometric wavelength shift of said characteristic the oxygen saturation of blood in said blood measurement path.
- the light may be applied over distinct paths in turn to said detector or examined in any convenient way to provide absorption wavelength information.
- the oximeter may include means to apply said light to a blood measurement path and to a reference path not including blood for measurement and means to apply light from said paths in turn to said means to detect light for comparative detection.
- the means to apply light in turn may include a mechanical or other light beam chopper.
- the oximeter may include a light source of known intensity/wavelength characteristic to avoid the need for comparative detection.
- the technique uses the direct relation of the wavelength shift of the absorption peak of the Soret spectrum with oxygen saturation percentage change.
- the absorption wavelength is determined by the method of tangents applied to the absorption characteristic in one of the ranges between known physiological endpoints 400 to 450, 465 to 520 and 530 to 600 nanometers and more specifically 410 to 440, 470 to 515 and 540 to 570 nanometers respectively.
- the method of tangents, or other appropriate analysis of the absorption spectrum is carried out in a microprocessor. While ratiometric techniques may be more convenient for some uses absolute measurement is possible given sufficient stability of wavelength information.
- the wavelength range 400 to 600 nanometers is used to assist in measurements through a fingernail.
- Optical fibres may be used to apply light to blood through the fingernail and receive light back from said blood.
- the arrangement may include a probe to enable measurement in a subject including means to introduce optical fibres, ends of which respectively emit light to blood in the subject and receive 1 ight from said blood.
- oxygenated blood is also known as oxyhaemoglobin, Hb ⁇ 2, and blood with no oxygen as reduced haemoglobin, Hb.
- Figures la, lb show the accepted characteristic of variation of the light absorbance of blood with wavelength for oxygen saturation at 100% and 0%, and ,in detail enlargements, parts of the characteristic of relevance in understanding the invention,
- FIG. 2 shows in block schematic form an oximeter according to the invention
- Figure 3 and 6 shows graphs useful in understanding the invention
- Figures 4 and 5 show arrangements for applying an oximeter according to the invention to a patient.
- Figure 2 shows in block schematic outline the elements of an oximeter to measure oxygen saturation of blood when the blood is available as a sample.
- a source 10 such as a quartz-halogen lamp is supplied to a scanning monochromator 11, such as a Mini-chrom 1 from the supplier ptr optics of the USA.
- the scanning monochromator should be operable to produce light output to nanometric accuracies in the range 350 to 600 nanometers or selected parts thereof and this can be achieved by incorporating within the monochromator an optical grating with the efficiency maximised over the range 330 to 600 nanometers, or appropriate parts.
- the supply to the lamp is stabilised and the lamp and monochromator together provide a source of monochromatic radiation whose bandwidth is defined by the physical parameters of the monochromator. A bandwidth less than 4 nanometers and preferably less than one nanometer is suitable, although a bandwidth less than 0.5 nanometer may be desirable in some cases.
- the monochromator has a control connection 12.
- the nanometric light from the monochromator 11 is applied to a first beam splitter 21 which provides two output beams, one 27 as a reference the other 28 for application to a sample in holder 22.
- Mirrors 23, 24 conveniently return the reference output to a further beam splitter 25 acting to bring into a common path the reference 27 and beam 29 of the light of beam 28 which has passed through the sample holder 22.
- a beam chopper 26 is arranged to chop the beams synchronously so that phase sensitive detection can be used.
- An optical detector 31 detects the intensity of the light emerging from the beam splitter in the common path and the detector output is supplied via a lock-in amplifier 32, coupled by connection 33 to the beam chopper 26, to a microprocessor 34.
- the microprocessor is connected to the scanning monochromator by two-way connection 12.
- an ultra-stable optical source can be used to avoid the need for a reference channel and an optical chopper to produce it.
- the radiation characteristic of the source is stored within the microprocessor memory and is used to compensate the measurements.
- Figure 2 omit items 11 and 34 and replace item 31 with a dispersive device such as a prism or a diffraction grating and a linear detector in the form of a charge coupled device to respond to the spectrum produced by the dispersive device.
- An optional band pass filter may replace item 11. Operation is as follows. Light from source 10, the quartz-halogen lamp, is supplied, through the optional band pass filter if used, to a first beam splitter 21 which provides two output beams, one 27 as a reference the other 28 for application to a sample in holder 22. Mirrors 23,34 conveniently return the reference output to a further beam splitter 25 acting to bring into a common path the reference 27 and beam 29 of the light of beam 28 which passed through the sample holder 22.
- a beam chopper 26 is arranged to chop the beams synchronously so that phase sensitive detection can be used.
- Light emerging from the beam splitter in the common path is incident on the dispersive device and emerges as a optical spectrum alternately related to the material in the sample holder and to the reference beam.
- the spectrum so formed is arranged to fall onto the elements of the charge coupled device (CCD) array with the bluest wavelength at the first element and the reddest wavelength at the last element (or vice-versa).
- the CCD is scanned from the first element to the last element to collect information about the optical spectrum. This scanning is conveniently performed under the control of a microprocessor via a suitable circuit link and the element information is returned to the microprocessor via another circuit link.
- the whole procedure is synchronised by the microprocessor to the beam chopper 26 via link 33 in order to produce sample and reference spectra information.
- an ultra-stable optical source can be used to avoid the need for a reference channel and an optical chopper to produce it.
- the radiation characteristic of the source is stored within the microprocessor memory and is used to compensate the measurements.
- Algorithms within the microprocessor provide means for the determination of the specific absorbtion wavelength of the sample in the sample holder 22 for the shift of the specific absorbtion characteristic in the range of the known physiological points. It has been found, as shown in Figure 3, that the oxygen saturation of blood is related to the wavelength of peak absorption in the Soret region range, 400 to 450 nanometers. As seen in the insert to Figure 1 there are distinct peaks of the absorption characteristics at 0% and 1007, oxygen saturation. The presence of these distinct peaks produces an identifiable variation in absorption with oxygen saturation. Accordingly from the determination of absorption peak in this range the oxygen saturation can be assessed and indicated by a rapid simple measurement of a sample.
- the graph in Figure 3 relates to a particular method of determining the peak and thence the oxygen saturation percentage which has been found to be convenient.
- the method employed is the method of tangents where the tangents to the points of inflection of the absorption characteristic on each side of the absorption peak are used to indicate by their intersection the wavelength for the peak.
- the "peak” need not be the peak in visual terms but is a repeatably determinable parameter of the particular type of instrument used to embody the invention.
- the regions 465 to 520 and 530 to 600 nanometres have similar distinct peaks, or troughs, in the characteristics and therefore the ability to provide the identifiable variation in absorption with saturation as a repeatable parameter.
- Figure 6 shows a graph similar to Figure 3 but for the trough region 480 to 500 nanometres.
- the techniques for securing and handling the sample are well-known and should be applied.
- a removable optical cuvette can be used for a static sample while a column can be used for the continuous flow of a sample.
- the light is passed through a sample in a holder, i.e. an in vitro technique.
- Figure 4 shows in outline apparatus by which the arrangement of Figure 2 can be coupled to a patient without penetration of the skin. The apparatus in Figure 4 replaces the optical chamber 22 of Figure 2.
- Light from beam 28 is directed by a mirror 41 along a fibre optic 43.
- a holder 45 is arranged to position fibre optic 43 over a finger or toe nail essentially normal thereto to direct light beam 48 through the nail.
- a further fibre optic 44 is positioned by holder 45 to collect light from fibre optic 43 reflected, as indicated generally at 49, from the capilliary bed.
- Light collected by fibre optic 44 is directed by mirror 42 towards the beam chopper 26 and thence to the rest of the Figure 2 arrangement.
- Figure 5 shows in outline apparatus by which the arrangement of Figure 2 can be coupled to a patient and applied to a vein, artery or organ by puncture.
- a structure 51 like a hypodermic needle or indwelling flexible catheter, which houses two fibre optics 52, 53.
- the structure 51 is arranged to puncture the skin and take the output and input ends of fibres 52, 53 to the region of interest.
- Light 58 emerging from fibre optic 52 returns from the area of interest as light 59 for collection by fibre optic 53.
- Elements 28, 41, 42 and 26 are as described above. The general techniques for the above devices will be readily apparent to those skilled in the art and will not be described further.
- microprocessor control is used. Typically arrangement and operation is as follows.
- the instrument is run under microprocessor control.
- the scanning monochromator is driven by a stepper motor and gearbox assembly.
- the microprocessor monitors the position of the grating, and hence the wavelength of light produced, and correlates this information with the digitised signal obtained from the optical detector. All this information is then stored as a bit pattern in a random access memory (RAM).
- RAM random access memory
- the mathematical operation, already described, to establish the wavelength of peak absorption (maximum or minimum) is contained within the software of the microprocessor. Data relating to the spectral calibration characteristics of the blood is stored in memory within the instrument.
- the peak wavelength value is then used as a pointer in a look-up table to establish the oxygen saturation of the sample.
- Using a variety of calibration parameters stored in a look-up table allows the instrument to be flexible so that depending on the clinical situation the most appropriate characteristic or group of characteristics can be chosen to produce statistically the best reading for oxygen saturation. Furthermore the availability of several regions where oxygen saturation can be measured permits cross-checks and possible improvements in accuracy.
- Optical reference points are provided within the monochromator scanning system by inclusion of one or more standard wavelength sources. These allow the microprocessor to calibrate the monochromator.
- this instrument may incorporate measurement circuits, sensors and algorithms based on existing technology to measure other parameters in the sample such as pH, pC0 2 and other haemoglobin derivatives. This, in addition to the scanning elements outlined above, would lead to a comprehensive instrument that could be used as a laboratory standard.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Ecology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
La technique de l'oxymètre, c'est-à-dire la mesure de la saturatiion d'oxygène du sang d'un sujet, consiste à examiner la caractéristique d'absorption dudit sang sur une base nanométrique sur une plage de longueur d'ondes comprise entre 350 et 600 nanomètres, à déterminer la caractéristique d'absorption spécifique nanométrique, et directement à partir du décalage de la longueur d'ondes de ladite caractéristique d'absorption spécifique tirée des points terminaux physiologiques connus, le pourcentage de saturation d'oxygène effectif.The oximeter technique, i.e. measuring the oxygen saturation of a subject's blood, consists of examining the absorption characteristic of said blood on a nanometric basis over a length range of waves between 350 and 600 nanometers, to determine the specific nanometric absorption characteristic, and directly from the offset of the wavelength of said specific absorption characteristic taken from known physiological end points, the percentage of saturation of effective oxygen.
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8917187 | 1989-07-27 | ||
GB898917187A GB8917187D0 (en) | 1989-07-27 | 1989-07-27 | Oximeters |
GB909003323A GB9003323D0 (en) | 1989-07-27 | 1990-02-14 | Oximeters |
GB9003323 | 1990-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0484442A1 true EP0484442A1 (en) | 1992-05-13 |
Family
ID=26295670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19900912344 Pending EP0484442A1 (en) | 1989-07-27 | 1990-07-27 | Oximeters |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0484442A1 (en) |
JP (1) | JPH05504266A (en) |
WO (1) | WO1991001678A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1364292A (en) * | 1992-02-28 | 1993-09-13 | Theodore E. Cadell | Non-invasive device and method for determining concentrations of various components of blood or tissue |
AU4634799A (en) | 1998-07-04 | 2000-01-24 | Whitland Research Limited | Non-invasive measurement of blood analytes |
EP1598003A3 (en) | 1998-08-13 | 2006-03-01 | Whitland Research Limited | Optical device |
US7190985B2 (en) | 2004-02-25 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Oximeter ambient light cancellation |
US7392075B2 (en) | 2005-03-03 | 2008-06-24 | Nellcor Puritan Bennett Incorporated | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
US7319894B2 (en) | 2005-09-13 | 2008-01-15 | Edwards Lifesciences Corporation | Continuous spectroscopic measurement of total hemoglobin |
US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8750953B2 (en) | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US8521246B2 (en) | 2010-07-29 | 2013-08-27 | Covidien Lp | Cable cross talk suppression |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3136310A (en) * | 1960-01-18 | 1964-06-09 | Bausch & Lomb | Optical catheter |
US4060327A (en) * | 1976-09-13 | 1977-11-29 | International Business Machines Corporation | Wide band grating spectrometer |
DE3615973A1 (en) * | 1985-08-28 | 1987-11-19 | Siegfried Dipl Phys Stiller | Method for continuously measuring the haemoglobin concentration in an extracorporeal circulation |
DE3700577A1 (en) * | 1987-01-10 | 1988-07-21 | Helge Eichholz | Method and examination device for examining human or animal tissue or human or animal body fluid to determine whether it contains a specific substance |
DE3872545T2 (en) * | 1987-02-23 | 1993-02-11 | Sumitomo Electric Industries | DEVICE FOR MEASURING THE METABOLISM OF A TISSUE. |
-
1990
- 1990-07-27 JP JP51147790A patent/JPH05504266A/en active Pending
- 1990-07-27 WO PCT/GB1990/001170 patent/WO1991001678A1/en not_active Application Discontinuation
- 1990-07-27 EP EP19900912344 patent/EP0484442A1/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO9101678A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH05504266A (en) | 1993-07-08 |
WO1991001678A1 (en) | 1991-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0721579B1 (en) | Non-spectrophotometric measurement of analyte concentrations and optical properties of objects | |
KR100893432B1 (en) | A method for noninvasive measurement of a target analyte property in a tissue sample and an apparatus therefor | |
US5372135A (en) | Blood constituent determination based on differential spectral analysis | |
US4854699A (en) | Backscatter oximeter | |
US5725480A (en) | Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds | |
USRE39672E1 (en) | Method and devices for laser induced fluorescence attenuation spectroscopy | |
US5676143A (en) | Apparatus for analytical determination of glucose in a biological matrix | |
US6026314A (en) | Method and device for noninvasive measurements of concentrations of blood components | |
EP0484442A1 (en) | Oximeters | |
US5974337A (en) | Method and apparatus for rapid non-invasive determination of blood composition parameters | |
US6741875B1 (en) | Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths | |
US20120209094A1 (en) | Monitoring blood constituent levels in biological tissue | |
US6088087A (en) | Transcutaneous measurement of substance in body tissues or fluid | |
CA2383727A1 (en) | Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths | |
AU2002249985A1 (en) | Noninvasive measurement of glucose through the optical properties of tissue | |
CA2597859A1 (en) | Method and apparatus for determining blood analytes | |
GB2235288A (en) | Oximeters | |
US8126527B2 (en) | Method and system for determining the contribution of hemoglobin and myoglobin to in vivo optical spectra | |
US20080214911A1 (en) | Method and Device for Determining Blood Components Using Ratiometric Absolute Pulse Spectroscopy | |
KR19990029222A (en) | Method and apparatus for measuring blood component concentration in blood | |
KR100883153B1 (en) | Instrument for noninvasively measuring blood sugar level |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920121 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BRITISH TECHNOLOGY GROUP LTD |
|
17Q | First examination report despatched |
Effective date: 19940509 |
|
18R | Application refused |
Effective date: 19950327 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19941121 |
|
D18R | Application refused (deleted) | ||
R18D | Application deemed to be withdrawn (corrected) |
Effective date: 19941122 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8580 Free format text: IM HEFT 35/95, SEITE 11631, SP.2: DIE VEROEFFENTLICHUNG IST ZU STREICHEN |
|
18RA | Request filed for re-establishment of rights before grant |
Effective date: 19951109 |
|
D18Z | Request filed for re-establishment of rights before grant (deleted) |